Association of arrhythmia-related genetic variants with phenotypes documented in electronic medical records

JAMA - Journal of the American Medical Association

Volumn 315, Issue 1, 2016, Pages 47-57

  Van Driest, Sara L ^a   Wells, Quinn S ^a   Stallings, Sarah ^a   Bush, William S ^a,b   Gordon, Adam ^c   Nickerson, Deborah A ^c   Kim, Jerry H ^c   Crosslin, David R ^c   Jarvik, Gail P ^c   Carrell, David S ^d   Ralston, James D ^d   Larson, Eric B ^d   Bielinski, Suzette J ^e   Olson, Janet E ^e   Ye, Zi ^e   Kullo, Iftikhar J ^e   Abul Husn, Noura S ^f   Scott, Stuart A ^f   Bottinger, Erwin ^f   Almoguera, Berta ^g   Connolly, John ^g   Chiavacci, Rosetta ^g   Hakonarson, Hakon ^g,h   Rasmussen Torvik, Laura J ⁱ   Pan, Vivian ⁱ   Persell, Stephen D ⁱ   Smith, Maureen ⁱ   Chisholm, Rex L ⁱ   Kitchner, Terrie E ^j   He, Max M ^j   Brilliant, Murray H ^j   Wallace, John R ^k   Doheny, Kimberly F ^l   Shoemaker, M Benjamin ^a   Li, Rongling ^m   Manolio, Teri A ^m   Callis, Thomas E ⁿ   Macaya, Daniela ^o   Williams, Marc S ^p   Carey, David ^p   Kapplinger, Jamie D ^e   Ackerman, Michael J ^e   Ritchie, Marylyn D ^k,p   Denny, Joshua C ^a   Roden, Dan M ^a   more..

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d GROUP HEALTH RESEARCH INSTITUTE   (United States)

^e MAYO CLINIC   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

^j MARSHFIELD CLINIC   (United States)

^k PENNSYLVANIA STATE UNIVERSITY   (United States)

^l JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

ⁿ TRANSGENOMIC INC   (United States)

^o GENEDX   (United States)

^p GEISINGER HEALTH SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ERG1 POTASSIUM CHANNEL; POTASSIUM CHANNEL HERG; SCN5A PROTEIN, HUMAN; SODIUM CHANNEL NAV1.5;

AGED; ALLELE; BRUGADA SYNDROME; CLINICAL TRIAL; ELECTRONIC MEDICAL RECORD; ETHNOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETIC VARIABILITY; GENETICS; GENOMICS; HEART ARRHYTHMIA; HETEROZYGOTE; HUMAN; INCIDENTAL FINDING; LABORATORY; MALE; MIDDLE AGED; MISSENSE MUTATION; MULTICENTER STUDY; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHENOTYPE; PROSPECTIVE STUDY; RANDOMIZATION; STANDARDS; VERY ELDERLY; YOUNG ADULT;

AGED; AGED, 80 AND OVER; ALLELES; ARRHYTHMIAS, CARDIAC; BRUGADA SYNDROME; ELECTRONIC HEALTH RECORDS; ETHER-A-GO-GO POTASSIUM CHANNELS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENETIC VARIATION; GENOMICS; HETEROZYGOTE; HUMANS; INCIDENTAL FINDINGS; LABORATORIES; MALE; MIDDLE AGED; MUTATION, MISSENSE; NAV1.5 VOLTAGE-GATED SODIUM CHANNEL; PHENOTYPE; PROSPECTIVE STUDIES; RANDOM ALLOCATION; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84953297333     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.17701     Document Type: Article

References (35)

1. Green RC, Berg JS, Grody WW, et al; American College of Medical Genetics and Genomics. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013;15(7):565-574.
2. American College of Medical Genetics and Genomics. Incidental findings in clinical genomics: a clarification. Genet Med. 2013;15(8):664-666.
3. Green RC, Berg JS, Berry GT, et al. Exploring concordance and discordance for return of incidental findings from clinical sequencing. Genet Med. 2012;14(4):405-410.
4. Wolf SM, Crock BN, Van Ness B, et al. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med. 2012;14(4):361-384.
5. Clayton EW, McGuire AL. The legal risks of returning results of genomics research. Genet Med. 2012;14(4):473-477.
6. Jarvik GP, Amendola LM, Berg JS, et al; eMERGE Act-ROR Committee and CERC Committee; CSER Act-RORWorking Group. Return of genomic results to research participants: the floor, the ceiling, and the choices in between. Am J Hum Genet. 2014;94(6):818-826.
7. Amendola LM, Dorschner MO, Robertson PD, et al. Actionable exomic incidental findings in 6503 participants: challenges of variant classification. Genome Res. 2015;25(3):305-315.
8. Tabor HK, Auer PL, Jamal SM, et al; NHLBI Exome Sequencing Project. Pathogenic variants for Mendelian and complex traits in exomes of 6,517 European and African Americans: implications for the return of incidental results. Am J Hum Genet. 2014;95(2):183-193.
9. Pathak J, Kho AN, Denny JC. Electronic health records-driven phenotyping: challenges, recent advances, and perspectives. J AmMed Inform Assoc. 2013;20(e2):e206-e211.
10. Newton KM, Peissig PL, Kho AN, et al. Validation of electronic medical record-based phenotyping algorithms: results and lessons learned from the eMERGE network. J AmMed Inform Assoc. 2013;20(e1):e147-e154.
11. Denny JC. Chapter 13: Mining electronic health records in the genomics era. PLoS Comput Biol. 2012;8(12):e1002823.
12. Rasmussen-Torvik LJ, Stallings SC, Gordon AS, et al. Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems. Clin Pharmacol Ther. 2014;96(4): 482-489.
13. Schwartz PJ, Ackerman MJ, George AL Jr, Wilde AAM. Impact of genetics on the clinical management of channelopathies. J AmColl Cardiol. 2013;62(3):169-180.
14. Crosslin DR, Robertson PD, Carrell DS, et al. Prospective participant selection and ranking to maximize actionable pharmacogenetic variants and discovery in the eMERGE Network. Genome Med. 2015;7(1):67.
15. DePristo MA, Banks E, Poplin R, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43(5):491-498.
16. Landrum MJ, Lee JM, Riley GR, et al. Clin Var: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42(Database issue):D980-D985.
17. Wang Q, Chen S, Chen Q, et al. The common SCN5A mutation R1193Q causes LQTS-type electrophysiological alterations of the cardiac sodium channel. J Med Genet. 2004;41(5):e66.
18. Hwang HW, Chen JJ, Lin YJ, et al. R1193Q of SCN5A, a Brugada and long QT mutation, is a common polymorphism in Han Chinese. J Med Genet. 2005;42(2):e7.
19. Vincent GM, Timothy KW, Leppert M, Keating M. The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. N Engl J Med. 1992;327(12):846-852.
20. Goldenberg I, Zareba W, Moss AJ. Long QT syndrome. Curr Probl Cardiol. 2008;33(11):629-694.
21. Earle N, Crawford J, Smith W, et al. Community detection of long QT syndrome with a clinical registry: an alternative to ECG screening programs? Heart Rhythm. 2013;10(2):233-238.
22. Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120(18):1761-1767.
23. Quaglini S, Rognoni C, Spazzolini C, Priori SG, Mannarino S, Schwartz PJ. Cost-effectiveness of neonatal ECG screening for the long QT syndrome. Eur Heart J. 2006;27(15):1824-1832.
24. Patel SS, Anees S, Ferrick KJ. Prevalence of a Brugada pattern electrocardiogram in an urban population in the United States. Pacing Clin Electrophysiol. 2009;32(6):704-708.
25. Ng D, Johnston JJ, Teer JK, et al; NIH Intramural Sequencing Center (NISC) Comparative Sequencing Program. Interpreting secondary cardiac disease variants in an exome cohort. Circ Cardiovasc Genet. 2013;6(4):337-346.
26. Lahtinen AM, Havulinna AS, Noseworthy PA, et al. Prevalence of arrhythmia-associated gene mutations and risk of sudden cardiac death in the Finnish population. Ann Med. 2013;45(4):328-335.
27. Richards S, Aziz N, Bale S, et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405-424.
28. Rehm HL, Berg JS, Brooks LD, et al; ClinGen. ClinGen: the Clinical Genome Resource. N Engl J Med. 2015;372(23):2235-2242.
29. Korf BR, Rehm HL. New approaches to molecular diagnosis. JAMA. 2013;309(14):1511-1521.
30. MacArthur DG, Manolio TA, Dimmock DP, et al. Guidelines for investigating causality of sequence variants in human disease. Nature. 2014;508 (7497):469-476.
31. Ackerman MJ, Tester DJ, Jones GS, Will ML, Burrow CR, Curran ME. Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome. Mayo Clin Proc. 2003;78(12):1479-1487.
32. Ackerman MJ, Splawski I, Makielski JC, et al. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm. 2004;1 (5):600-607.
33. UniProt Consortium. UniProt: a hub for protein information. Nucleic Acids Res. 2015;43(Database issue):D204-D212.
34. Wang Q, Li Z, Shen J, Keating MT. Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics. 1996;34(1): 9-16.
35. Splawski I, Shen J, Timothy KW, Vincent GM, Lehmann MH, Keating MT. Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1. Genomics. 1998;51(1):86-97.